Intellia Therapeutics
Rachel Emsley specializes in patent law, with a focus on electronic technology, computer software, business methods, robotics, internet applications, and medical devices. Rachel has served in various legal roles at different companies, including as a Senior Counsel at Intellia Therapeutics, Inc., a Patent Attorney at Finnegan, Henderson, Farabow, Garrett & Dunner LLP, and as an Applications Engineer at Analog Devices. Rachel has a JD in Intellectual Property Law and a BSEE in Electrical Engineering.
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.